Team:Uppsala/chassi-group

From 2013.igem.org

(Difference between revisions)
 
(One intermediate revision not shown)
Line 65: Line 65:
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                     <ul>
                                                     <ul>
-
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">P-coumaric acid</a></li>
+
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">p-Coumaric acid</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
Line 86: Line 86:
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<ul>
<ul>
-
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">P-Coumaric acid</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">Kinetic model</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
 +
 +
<li><a href="https://2013.igem.org/Team:Uppsala/toxicity-model">Toxicity model</a></li>
</ul></li>
</ul></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
Line 96: Line 98:
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
 +
                                                <li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li>
</ul></li>
</ul></li>
Line 105: Line 108:
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li>
-
 
+
<li><a href="https://2013.igem.org/Team:Uppsala/bioart">BioArt</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld">A LactoWorld</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/killswitches">Killswitches</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/realization">Patent</a></li>
</ul></li>
</ul></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a>
+
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li>  
-
                                <ul>
+
-
                                    <li><a href="https://2013.igem.org/Team:Uppsala/collaboration">Collaboration</a></li>
+
-
                                </ul></li>  
+
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
                                     <ul>
                                     <ul>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
 +
                                        <li><a href="https://2013.igem.org/Team:Uppsala/protocols">Protocols</a></li>
                                     </ul></li>
                                     </ul></li>
</ul>
</ul>
Line 122: Line 126:
<div id="main_content"> <!-- Put content here -->
<div id="main_content"> <!-- Put content here -->
-
     <h1>Chassi group</h1>
+
     <h1 class="main-title">Chassi group</h1>
<img class="team-pic-template" src="https://static.igem.org/mediawiki/2013/9/9b/Genet_9.jpg">
<img class="team-pic-template" src="https://static.igem.org/mediawiki/2013/9/9b/Genet_9.jpg">
Line 270: Line 274:
<div id="bottom-pic">
<div id="bottom-pic">
-
<img class="bottom-pic" src="https://static.igem.org/mediawiki/2013/a/aa/Bottom_picture.png">
+
</div>
</div>

Latest revision as of 19:56, 27 October 2013

Chassi group

Anders Edlund

When/Why did your interest in bioengineering start?
-I have always been fascinated with life and biology. I started out studying economics but switched fields to biotechnology because I felt I had a stronger interest and I feel that there is a huge untapped potential today in this field.

Does your primary interest lie in engineering or in biology/biotechnology?
-Definately biotechnology.

Why did you choose to participate in iGEM?
-I participated last year and felt that I learned a lot and that it was fun. I felt that it would be a great experience to do it again. I also feel the synthetic biology approach is very interesting and promising and I wanted a chance to explore it further.

Stephanie Elizabeth Herman

When/Why did your interest in bioengineering start?
-My interest in bioengineering began in my last year in high school. I got the chance to work at Stockholm University and explore how apoptosis works at tumor human nervcells. It wasn’t exactly bioengineering, but later on I discovered that there was a way to combine my interests in building stuff and cell biology, bioengineering!

Does your primary interest lie in engineering or in biology/biotechnology?
-Both

Why did you choose to participate in iGEM?
-I wanted to contribute to the growth in synthetic biology. Also I thought it was fun to finally do something outside of my studies.

Alona Nyberg

When/Why did your interest in bioengineering start?
-In early high school.

Does your primary interest lie in engineering or in biology/biotechnology?
-Both

Why did you choose to participate in iGEM?
-To gain valuable experience in fundamental laboratory work, as well as in working in a project environment. Of course, the social aspect of it also played a big part in my decision.

Anton Berglund

When/Why did your interest in bioengineering start?
-I have always been interested in how nature and biology works.

Does your primary interest lie in engineering or in biology/biotechnology?
-Both

Why did you choose to participate in iGEM?
-I participated last year and had lots of fun. I wanted to use my experience from the previous year and try out the competition once more.

Mikael Strandgren

When/Why did your interest in bioengineering start?
-During the first weeks in X (The Molecular Biotechnology engineering program in Uppsala)

Does your primary interest lie in engineering or in biology/biotechnology?
-Both

Why did you choose to participate in iGEM?
-It seemed fun so I thought it would be nice to try!

Christoffer Ahlström

When/Why did your interest in bioengineering start?
-I started to consider going into something with bio- when i was around the age of 16. It seemed like a fun field with many undiscovered mysteries as well as much work left to do.

Does your primary interest lie in engineering or in biology/biotechnology?
-Both.

Why did you choose to participate in iGEM?
-I thought it sounded interesting and that it would be a good occupation during the summer. It is also similar to possible jobs in the future so it's a good idea to try it out.

Viktor Blomkvist

When/Why did your interest in bioengineering start?
-I have always been interested in biology, but it was not until I applied for the university my interest in biotech started.

Does your primary interest lie in engineering or in biology/biotechnology?
-Both.

Why did you choose to participate in iGEM?
-I thought it would be nice to get some more laboratory experience and my friends who participated last year recommended it.

Viktor Törnblom

When/Why did your interest in bioengineering start?
-I have always been interested in biology but my interest in bioengineering didn't start until I happened to come across bioengineering when applying to university.

Does your primary interest lie in engineering or in biology/biotechnology?
-Biology.

Why did you choose to participate in iGEM?
-I chose to participate in iGEM after hearing of a former iGEM-project that sought to decrease the desertification. The thought of students contributing to science this way was very intriguing to me.